Skip to main content
SpringerLink
Log in

Treatment Delay in Surgically-Treated Colon Cancer: Does It Affect Outcomes?

  • Colorectal Cancer
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Treatment delay, or the time lapse between diagnosis and surgery, may have a detrimental effect on cancer outcomes. This study assesses the effect of treatment delay on cancer-related outcomes in a large, continuous series of surgically treated colon cancer patients.

Methods

All surgical colon cancer cases at our center from 2004 through 2011 were reviewed. Patients who underwent preoperative chemotherapy, emergency admissions, palliative cases, and incidental and postoperative diagnoses were excluded. Treatment delay was correlated with outcomes in univariate and multivariate regression and proportional hazards models.

Results

In 769 included patients, for every treatment-delay quartile increase, odds of death decreased by an odds ratio (OR) of 0.78 (p = 0.001), and metastatic recurrence by OR 0.78 (p = 0.013). Shorter survival duration had a hazard ratio (HR) of 0.81 (p = 0.001) and shorter disease-free survival HR 0.72 (p < 0.001). Multivariate regression adjusting for baseline staging greatly reduces these ratios, and makes them non-significant. Similar patterns were shown in high-risk subsets, including stage III disease, ethnic minorities, patients with positive margins, and extramural vascular invasion.

Conclusions

The inverse relation between treatment delay and survival and recurrence reflected adequate prioritization of advanced and high-risk cases and concurrently showed that, matched for stage and risk categories, treatment delay was not associated with worse cancer outcomes for patients with colon cancer. A reasonable delay between diagnosis and subsequent surgery is not detrimental to patient outcomes and permits more flexibility in scheduling and justifies allowing time to complete proper preoperative evaluation and staging, improving the quality and safety of resection and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Brú A, Albertos S, Luis Subiza J, García-Asenjo JL, Brú I. The universal dynamics of tumor growth. Biophys J. 2003;85(5):2948–61.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Retsky MW, Swartzendruber DE, Wardwell RH, Bame PD. Is Gompertzian or exponential kinetics a valid description of individual human cancer growth? Med Hypotheses. 1990;33(2):95–106.

    Article  PubMed  CAS  Google Scholar 

  3. Shen Y, Huang X. Nonparametric estimation of asymptomatic duration from a randomized prospective cancer screening trial. Biometrics. 2005;61(4):992–9.

    Article  PubMed  Google Scholar 

  4. McLaughlin JM, Anderson RT, Ferketich AK, Seiber EE, Balkrishnan R, Paskett ED. Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer. J Clin Oncol. 2012;30(36):4493–500.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Sun M, Abdollah F, Hansen J, et al. Is a treatment delay in radical prostatectomy safe in individuals with low-risk prostate cancer? J Sex Med. 2012;9(11):2961–9.

    Article  PubMed  Google Scholar 

  6. Yun YH, Kim YA, Min YH, et al. The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery. Ann Oncol. 2012;23(10):2731–7.

    Article  PubMed  CAS  Google Scholar 

  7. Aragoneses FG, Moreno N, Leon P, Fontan EG, Folque E; Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S). Influence of delays on survival in the surgical treatment of bronchogenic carcinoma. Lung Cancer. 2002;36(1):59–63.

    Article  PubMed  Google Scholar 

  8. Eshuis WJ, van der Gaag NA, Rauws EAJ, et al. Therapeutic delay and survival after surgery for cancer of the pancreatic head with or without preoperative biliary drainage. Ann Surg. 2010;252(5):840–9.

    Article  PubMed  Google Scholar 

  9. Iversen LH, Antonsen S, Laurberg S, Lautrup MD. Therapeutic delay reduces survival of rectal cancer but not of colonic cancer. Br J Surg. 2009;96(10):1183–9.

    Article  PubMed  CAS  Google Scholar 

  10. Langenbach MR, Schmidt J, Neumann J, Zirngibl H. Delay in treatment of colorectal cancer: multifactorial problem. World J Surg. 2003;27(3):304–8.

    Article  PubMed  Google Scholar 

  11. Ristvedt SL, Birnbaum EH, Dietz DW, Fleshman JW, Kodner IJ, Read TE. Delayed treatment for rectal cancer. Dis Colon Rectum. 2005;48(9):1736–41.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Hamilton SR. The adenoma-adenocarcinoma sequence in the large bowel: variations on a theme. J Cell Biochem Suppl. 1992;16G:41–6.

    Article  PubMed  CAS  Google Scholar 

  13. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer. 1975;36(6):2251–70.

    Article  PubMed  CAS  Google Scholar 

  14. Minsky BD, Mies C, Rich TA, Recht A, Chaffey JT. Potentially curative surgery of colon cancer: the influence of blood vessel invasion. J Clin Oncol. 1988;6(1):119–27.

    PubMed  CAS  Google Scholar 

  15. Adams SV, Ahnen DJ, Baron JA, et al. Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry. World J Gastroenterol. 2013;19(21):3241–8.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Li M, Li JY, Zhao AL, Gu J. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas. Oncology. 2007;73(1–2):52–7.

    Article  PubMed  CAS  Google Scholar 

  17. Ward EE, Jemal AA, Cokkinides VV, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54(2):78–93.

    Article  PubMed  Google Scholar 

  18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of General Surgery & Gastrointestinal Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

    Ramzi Amri MSc, Liliana G. Bordeianou MD, Patricia Sylla MD & David L. Berger MD

Authors
  1. Ramzi Amri MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liliana G. Bordeianou MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patricia Sylla MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David L. Berger MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David L. Berger MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amri, R., Bordeianou, L.G., Sylla, P. et al. Treatment Delay in Surgically-Treated Colon Cancer: Does It Affect Outcomes?. Ann Surg Oncol 21, 3909–3916 (2014). https://doi.org/10.1245/s10434-014-3800-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-014-3800-9

Keywords

Search

Navigation